Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 145,580 | 129,846 | 123,187 | 116,593 | 117,715 |
| Operating Income | -145,580 | -129,846 | -123,187 | -116,593 | -117,715 |
| Other Income | 12,610 | 15,161 | 15,995 | 17,567 | 15,913 |
| Pre-tax Income | -132,970 | -114,685 | -107,192 | -99,026 | -101,802 |
| Net Income Continuous | -132,970 | -114,753 | -107,192 | -99,026 | -101,802 |
| Net Income | $-132,970 | $-114,753 | $-107,192 | $-99,026 | $-101,802 |
| EPS Basic Total Ops | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 |
| EPS Basic Continuous Ops | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 |
| EPS Diluted Total Ops | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 |
| EPS Diluted Continuous Ops | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.78 | -0.67 | -0.63 | N/A | N/A |
| EBITDA(a) | $-147,143 | $-134,158 | $-129,727 | $-124,709 | $-126,069 |